Education
About Us
Working with TipRanks
Follow Us
Cvrx, Inc. (CVRX)
:CVRX
CVRX Stock Chart & Stats
$9.27
-$0.03(-0.21%)
At close: 4:00 PM EST
$9.27
-$0.03(-0.21%)
Day’s Range― - ―
52-Week Range$4.30 - $18.55
Previous CloseN/A
Volume20.10K
Average Volume (3M)250.79K
Market Cap
$258.17M
Enterprise Value$176.58M
Total Cash (Recent Filing)$85.12M
Total Debt (Recent Filing)$50.18M
Price to Earnings (P/E)―
Beta1.06
Next Earnings
Jan 22, 2026EPS Estimate
-0.45Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.49
Shares Outstanding26,210,110
10 Day Avg. Volume312,621
30 Day Avg. Volume250,791
Financial Highlights & Ratios
PEG Ratio-0.14
Price to Book (P/B)4.03
Price to Sales (P/S)5.58
P/FCF Ratio-7.07
Enterprise Value/Market Cap0.68
Enterprise Value/Revenue3.15
Enterprise Value/Gross Profit3.71
Enterprise Value/Ebitda-3.89
Forecast
1Y Price Target
$12.67Price Target Upside36.68% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Clinical Trial ExpansionBENEFIT-HF was recently posted to clinicaltrials.gov, reaching another milestone for the company’s clinical and commercial efforts.
Financial PerformanceCVRX reported Q3/25 revenue of $14.7M, ahead of analyst estimates and consensus, indicating positive performance.
Reimbursement StabilityCMS kept CVRX’s Barostim procedure assigned to New Technology APC 1580, indicating stability.
Bears Say
Sales Rep TurnoverIncreased sales rep turnover and changes in its commercial organization may have a prolonged negative impact on results.
CVRx News
CVRX FAQ
What was Cvrx, Inc.’s price range in the past 12 months?
Cvrx, Inc. lowest stock price was $4.30 and its highest was $18.55 in the past 12 months.
What is Cvrx, Inc.’s market cap?
Cvrx, Inc.’s market cap is $258.17M.
When is Cvrx, Inc.’s upcoming earnings report date?
Cvrx, Inc.’s upcoming earnings report date is Jan 22, 2026 which is in 41 days.
How were Cvrx, Inc.’s earnings last quarter?
Cvrx, Inc. released its earnings results on Nov 05, 2025. The company reported -$0.49 earnings per share for the quarter, beating the consensus estimate of -$0.493 by $0.003.
Is Cvrx, Inc. overvalued?
According to Wall Street analysts Cvrx, Inc.’s price is currently Undervalued.
Does Cvrx, Inc. pay dividends?
Cvrx, Inc. does not currently pay dividends.
What is Cvrx, Inc.’s EPS estimate?
Cvrx, Inc.’s EPS estimate is -0.45.
How many shares outstanding does Cvrx, Inc. have?
Cvrx, Inc. has 26,210,110 shares outstanding.
What happened to Cvrx, Inc.’s price movement after its last earnings report?
Cvrx, Inc. reported an EPS of -$0.49 in its last earnings report, beating expectations of -$0.493. Following the earnings report the stock price went up 2.656%.
Which hedge fund is a major shareholder of Cvrx, Inc.?
Currently, no hedge funds are holding shares in CVRX
CVRx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.67 (36.68% Upside)
$12.67 (36.68% Upside)
Blogger Sentiment
Bullish
CVRX Sentiment 70%
Sector Average 68%
Sector Average 68%
Insider Transactions
Sold Shares
Worth $546.3K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-33.31%
12-Months-Change
Fundamentals
Return on Equity
-91.88%
Trailing 12-Months
Asset Growth
-12.80%
Trailing 12-Months
Company Description
Cvrx, Inc.
CVRx, Inc. is a medical device company focused on developing innovative therapies for patients with cardiovascular diseases. The company specializes in implantable technologies that target hypertension and heart failure, with its flagship product being the Barostim Therapy system. This system is designed to improve heart function and reduce blood pressure by stimulating the baroreceptors in the carotid artery. CVRx operates primarily in the healthcare sector, aiming to enhance patient outcomes through its advanced medical devices.
CVRX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects substantial progress with a notable increase in revenue, expanded commercial footprint, and improved gross margins. However, challenges remain with increased R&D expenses, higher interest expenses, and a net loss. The positive developments in clinical evidence and approval of a Category I CPT code are promising for future growth.View all CVRX earnings summariesCVRX Stock 12 Month Forecast
Average Price Target
$12.67
▲(36.68% Upside)
Technical Analysis
Ownership Overview
27.01% Insiders
6.70% Mutual Funds
29.48% Other Institutional Investors
30.79% Public Companies and
Individual Investors